Mastering US Market Access: What are proven Strategies for Success, Paul Hoffschmidt?

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

In this essential episode of the Market Access Podcast, we’re diving deep into the critical aspects of commercializing healthcare innovations in the US market. Whether you’re in medtech, pharma, biotech, or health tech, understanding the US healthcare landscape is key to your product’s success. Join us as Dr. Stefan Walzer and Paul Hoffschmidt share their wealth of knowledge on effective strategies for navigating this complex terrain.

Key Topics Covered:

  • Understanding US Market Access: An overview of the unique challenges and opportunities in the US healthcare system for new entrants.
  • Role of Healthcare Professionals: Insight into how healthcare professionals influence market access and product uptake.
  • Data-Driven Strategies: The importance of leveraging data in targeting and positioning your product effectively.
  • Commercialization Pathways: Expert advice on navigating regulatory, reimbursement, and distribution challenges.
  • Case Studies: Real-world examples of successful market entry and the lessons learned.
  • Future Trends: Predictions on how the US market access landscape may evolve and what it means for healthcare innovators.

Why You Should Listen:

  • Gain Expert Insights: Learn from leading experts with firsthand experience in the US healthcare market.
  • Strategic Advice: Receive actionable advice on overcoming the hurdles to market entry and expansion.
  • Stay Ahead: Understand the latest trends and how they impact market access strategies.

This episode is indispensable for CEOs, entrepreneurs, market access professionals, and anyone involved in the commercialization of healthcare innovations looking to penetrate or expand their presence in the US market.

Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts

MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de

#Medtech #MarketAccess #US #HealthcareSystem #MarketAccessPodcast

Beyond the CE Mark: How can we achieve Medtech Reimbursement in France, Dr. Benoit Salaun?

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

Join us for a fascinating dive into the complexities of French market access with our latest episode of the Map Podcast. Dr. Stefan Walzer, health economist and founder of Mars Market Access & Pricing Strategy, engages with Dr. Benoit Salaun, a seasoned expert in French healthcare reimbursement.

They unravel:

  • The nuances of the French healthcare system
  • The essentials of medical device reimbursement
  • The importance of demonstrating efficacy, safety, and affordability
  • The role of clinical evidence and the adaptability of international data to French contexts
  • The strategic considerations for medtech companies entering the French market

Whether you’re a healthcare professional, a medtech innovator, or a market access strategist, this episode is packed with insights on how to ensure your medical device not only enters the French market but also achieves the price it deserves.

Tune in to gain expert knowledge on creating a successful roadmap for market access in France, and discover if the “French way” aligns with your company’s goals.

🎧 Listen now and elevate your market access strategy! 

Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts

MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de

#Medtech #MarketAccess #HealthcareInnovation #FrenchHealthcareSystem #marketaccess #marketaccesspodcast

Remo Christen – Early paid access in Switzerland – Switzerland, wonderland? (Repost)

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

In this Podcast episode, Dr. Stefan Walzer is discussing the specifics of the Swiss market access & reimbursement including the famous article 71, which allows an early paid access.

Who else could better speak about the Swiss system with him than Remo Christen? Remo is working since > 20 years in the Swiss market access environment in a leading role at Roche’s Swiss affiliate.

In this episode, listeners will learn the specifics of the Swiss culture, the reimbursement process also in comparison to the German AMNOG and why Switzerland is attractive for drug launches.

Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts

MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de

How can we navigate the Complexities of Medical Devices Market Access in Spain, Sergio Gil?

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

Are you intrigued by the pulsing heart of Spain’s healthcare sector, or are you considering navigating the vibrant market of medical devices in Spain? Dive into our latest Market Access podcast episode where we unravel the complexities and dynamism of Spain’s medical landscape. 🇪🇸

Join us as Sergio Gill, a seasoned veteran with over three decades in the medical device industry, shares his invaluable insights. From understanding Spain’s unique regional healthcare powers to decoding the reimbursement conundrums, Sergio illuminates the path to successful market entry and what makes Spain not just culturally, but commercially captivating.

Here’s a sneak peek at what you’ll discover:

🔹 The striking differences between the pharmaceutical and medical device sectors in Spain.

🔹 An insider’s guide to Spain’s decentralized healthcare approach and how it impacts market access.

🔹 Key strategies for companies aiming to penetrate the Spanish market – straight from the expert.

🔹 The burgeoning world of digital health in Spain and the emerging trends to watch out for.

Whether you’re a startup eyeing Spain for your next big launch or a seasoned player looking to deepen your market footprint, this episode is packed with strategic gold.

✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: map-market-access.captivate.fm

MAP is the first and only bi-weekly #marketaccess podcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: marketaccess-pricingstrategy.de

#MedicalDevices #Healthcare #MarketAccess #Spain #Podcast #DigitalHealth #Innovation #BusinessStrategy

What is the secret of the cost-efficient healthcare system in Israel, Mirel Stelian? (Repost)

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

We are looking at Israel a lot recently, but did you know how innovative this rather small country is in terms of healthcare?

Israel spends only 7.6% of the GDP on healthcare – significantly less than most other Western OECD countries. At the same time, Israel has a higher life expectancy and lower infant mortality. So, better results for less money?! How does Israel do this?

Dr. Stefan Walzer and Mirel Stelian are discussing in depth, how the application and reimbursement process works and what options are available for companies who want to enter the Israeli market. If you want to understand the Israeli health care market and specifically the reimbursement process in Israel, you should not miss this episode. 

Take the chance to stay connected and subscribe with your favorite podcasting platform or directly listen on our website: MAP Podcasts

MAP is the first and only bi-weekly market access podcast provided by MArS. For more information about MArS Market Access and Pricing Strategy visit: marketaccess-pricingstrategy.de

 

#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #reimbursement #pricingstrategy #negotiations #pricing #europe #israel

The Startup Guide to Navigating Healthcare Reimbursement, Featuring Ron de Graaff

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

We are thrilled to announce our latest podcast episode, featuring a riveting conversation between our CEO Dr. Stefan Walzer and the esteemed healthcare reimbursement expert, Ron de Graaff. 

Ron, with his deep-rooted experience starting from 1978, shares his invaluable insights on the evolution of healthcare reimbursement, a journey from simpler times to today’s intricate landscape involving multiple stakeholders like health insurance companies.

🔍 Key Highlights:

– Ron’s path from founding his company in 1985, which has since assisted over 900 entities, including governments, in understanding medical technology markets.

– Challenges faced by startups in healthcare, often led by technical experts who struggle with the language and complexities of reimbursement processes.

– The criticality of startups understanding both the payer perspectives and the changing requirements of reimbursement systems across Europe.

– Ron’s advice to startups: comprehensively understand the reimbursement system of your target market and assess if your product is likely to be reimbursable.

This episode is a must-listen for anyone in the healthcare industry, particularly startups navigating the daunting world of reimbursement. Expect to gain a thorough understanding of how to strategically plan for reimbursement, the importance of being updated with current regulations, and how to choose the right market for your product.

🌟 Tune in for a blend of expert insights, practical advice, and a glimpse into the future of healthcare reimbursement strategies. For more information on early reimbursement planning utilizing artificial intelligence, visit max-insights.com.

✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQb

MAP is the first and only bi-weekly #marketaccess podcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf

#HealthcareReimbursement #StartupChallenges #MedicalTechnology #Podcast #HealthcareInnovation“

Navigating the Healthcare Startup Galaxy – key insights with Dr. Thomas Kerscher and Mark Anken.

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

🎧 Excited to share our CEO, Dr. Stefan Walzer’s newest Market Access podcast episode that’s nothing short of a masterclass for healthcare startups venturing into the European market!

In this engaging episode, Dr. Walzer sits down with Dr. Thomas Kerscher and Mark Anken, both titans in the healthcare and pharmaceutical sectors with over two decades of experience. Currently at the helm of advantage, they’re shaping the future of startups in this complex field. 🌍

Key Highlights:

1️⃣ Tailored Strategies: The critical need for startups to tailor their strategies based on product type and the unique healthcare landscapes of European countries.

2️⃣ Realistic Approach: The importance of balancing optimism with realism, especially when pitching to well-informed investors.

3️⃣ Scaling Up: The power of starting small, akin to Airbnb’s model, then scaling up based on market feedback and minimal business model alterations.

4️⃣ Innovation vs. Reimbursement: Understanding the delicate balance between being innovative and navigating the reimbursement strategies crucial for startup viability.

💡 The duo shares invaluable insights on the significance of understanding your target customer, the nuances of entering varied European markets, and the complexities startups face in aligning their business models with healthcare policies. They stress the importance of innovation, not just for product differentiation, but as a tool to address cost pressures in healthcare systems.

📈 For those in healthcare startups, this episode is a goldmine of advice on developing effective business plans, understanding investor expectations, and the imperative of global market awareness.

Join us in exploring these vital topics, and gain a wealth of knowledge to propel your healthcare startup to new heights. Don’t miss out on this incredible episode for a roadmap to success in the challenging yet rewarding realm of healthcare entrepreneurship.

#HealthcareStartups #MarketAccess #Podcast #Innovation #BusinessStrategy #HealthcareInvestment #EuropeanMarket #DrStefanWalzer

👉 Tune in to the full episode for a deep dive into these groundbreaking insights! 🎙️👇

How to navigate complexities, Aurelie Moser: Market Access in Digital Health vs. Drugs?

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

🎙️ Exciting Podcast Episode Is Here! 🎙️

In this episode of our podcast series, I’m excited to share that Stefan Walzer, a seasoned reimbursement expert, hosts the incredibly talented Amelie Moser, a business consultant with two decades of unparalleled expertise in market access!

🎯 What’s Happening?

Immerse yourself in the fascinating world of digital health and see how it sharply contrasts with traditional drug landscapes.

Grasp the challenges of moving global product strategies into local implementations, all through the lens of Aurelies experience.

Navigate the crucial role of ecosystem mapping, and learn why it’s important to engage all stakeholders.

💡 Key Takeaways:

Experience the dynamic nature of strategy adaptation — it’s an evolving process, not just a set document!

Join in on an enlightening discussion about the mindset shift crucial for companies making the leap from global to local viewpoints.

Gain perspective on balancing qualitative vs. quantitative data for local market achievement.

Uncover the unexplored complexities of digital health solutions and the challenges they pose.

✨ Special Mention: Dive deep with Aurelie as she discusses her founding venture, BAMBOOSTER, and how she plays a crucial role in connecting top pharma giants with startups in the digital health and AI sectors.

If the evolving landscape of healthcare piques your curiosity as much as it does mine, you won’t want to miss this episode. Listen now for this enlightening conversation! 🚀

🔗 Find the 3C Business Model Canvas here.

✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQb

MAP is the first and only bi-weekly #marketaccess podcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf

#DigitalHealth #MarketAccess #Podcast #HealthcareInnovation #LocalVsGlobal #StrategiesForSuccess

AMNOG 2.0 – significant changes for the industry since January 2023, correct – Dr. Flume?

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

Join us in the latest episode where pharmacist and head of a regional physicians association, Matthias Flume, engages in a thought-provoking discussion with host Stefan Walzer, exploring the intricate tapestry of reforms enveloped within the AMNOG (Arzneimittelmarktneuordnungsgesetz) 2.0, especially scrutinizing those unveiled in 2023!

🚀 Dive Deep into the Core of Pharmaceutical Reforms!

Matthias unearths various pivotal changes, including the mandated discounts for products with no additional benefit rating and the perceptible adjustments in the orphan drug area, dissecting the threshold reduction for annual sales in the full regular benefit assessment. 🚀

🌎 Explore the Global Impact!

Navigate through their insightful discussion on how these reforms potentially sculpt Germany’s presence on the global stage, especially in the orphan drugs market, and assess Germany’s unique positioning in evaluating them! 🌎

💡 Illuminating the Opaqueness of Drug Pricing!

Embark on a journey through the complexities and pragmatic implications of drug pricing, dissecting the nuances of arbitration boards, pricing mechanisms, and the often intricate physician prescription behaviors amidst the recent reforms. 💡

🤔 Facing the Challenges Head-On!

Explore the potential disconnect between pricing strategies and actual prescription practices, as our experts shed light on the vital need for enhancing transparency and communication with physicians regarding pricing negotiations and adjustments. 🤔

👥 Join Matthias and Stefan as they scrutinize the germane issues of drug pricing, contemplate future adjustments within the system, and ponder upon the possible shifts influenced by the upcoming national elections and continual changes within the healthcare landscape! 👥

🎧 Tune in to immerse yourself in a conversation that not only explores the multidimensional aspects of the healthcare and pharmaceutical reimbursement system but also poses potent questions regarding its future amidst regulatory and structural shifts! 🎧

A journey through the dynamics of pharmaceutical pricing and reforms awaits you, amplifying both economic and patient care perspectives amidst the shifting tides of the healthcare system in Germany! Don’t miss it! 🚀🚀

Inside the Swiss decision-makers – how does the system for drugs really work, Dr. Heiner Sandmeier?

Klicken Sie auf den unteren Button, um den Inhalt von player.captivate.fm zu laden.

Inhalt laden

Listen to this podcast on your favourite podcast player: https://lnkd.in/eGemZRTi

 

Switzerland is seen as a small but still attractive market for pharmaceuticals, even though that the Swiss decision-makers are considered as tough and sometimes even difficult. A core issue might especially be, that the assessment and negotiations primarily happen intransparently „behind the doors“. 

Dr. Heiner Sandmeier has been part of the drug evaluation committee advising the Swiss decision makers for over a century and opens his insights and secrets to all listeners. 

Some of the topics Dr. Sandmeier and reimbursement veteran Dr. Stefan Walzer discuss are as follows: 

  • What are the main drivers for a positive decision in Switzerland?
  • Who is involved in the decision process?
  • What are the challenges as well as possible solutions for the main issues?
  • What are the differences to other countries in Europe?

And last but not least: Why should you still consider to enter the Swiss market with an innovative pharmaceutical product?

✏️ Take the chance to stay connected and subscribe with your favorite podcast platform: https://lnkd.in/dyTZ3yQb

MAP is the first and only bi-weekly #marketaccess podcast provided by MArS. For more information about MArS Market Access & Pricing Strategy GmbH visit: https://lnkd.in/db8aQWf

#podcasthost #podcastshow #podcastepisode #marketaccess #marketaccesspodcast #pricingstrategy #negotiations #pricing #pharmaceuticals #switzerland #innovation #reimbursement